Trial shows wound closure and reduces infection in diabetic models, indicating a therapeutic strategy for wound treatment.
, RCGel significantly accelerated wound closure, suppressed infection and inflammation, promoted neovascularization and collagen deposition, and improved tissue remodeling in both diabetic noninfected and MRSA-infected wound models, without evident systemic toxicity. Overall, this work presented a microenvironment-adaptive multifunctional hydrogel dressing that integrated antibacterial, antioxidative, immunomodulatory, and pro-regenerative functions, offering a promising therapeutic strategy for infected diabetic wound treatment.
No takes yet. Share an insight, caveat, or question.
Mu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: